| We represent the needs and concerns of our target population in joint discussions with regulatory authorities and industry stakeholders across a range of networks. | 부인과
> 부인과: 기타 | 규제 파트너십
> 규제 기관과의 협력 | 100,000 | National | Sometimes | 115028466428 |
| We periodically prepare statements for submission as supporting documentation to drug reimbursement applications. | 지정되지 않음
> 지정되지 않음 | 규제 파트너십
> 건강기술평가(HTA) 및 급여 검토에 참여 | 10,000 | National | Sometimes | 114998339214 |
| We periodically prepare submissions to accompany medicine reimbursement applications. | 지정되지 않음
> 지정되지 않음 | 규제 파트너십
> 건강기술평가(HTA) 및 급여 검토에 참여 | 10,000 | National | Sometimes | 114998339214 |
| We provide formal submissions, and I have personally participated in consultation processes — for example, as part of the working group tasked with developing the pharmaceutical reimbursement system. | 뼈
> 골관절염 | 규제 파트너십
> 건강기술평가(HTA) 및 급여 검토에 참여 | 10,000 | National | Regularly | 114998343058 |
| Patient organisation submissions to the authorities responsible for reimbursement decisions. | 암
> 암: 유방 | 규제 파트너십
> 건강기술평가(HTA) 및 급여 검토에 참여 | 10,000 | National | Sometimes | 115043746918 |
| We are a patient organisation representing individuals living with osteoporosis, and we advocate for the patient perspective in all our interactions with regulatory authorities. | 뼈
> 골다공증 | 규제 파트너십
> 정책 입안자/규제 기관과의 회의 참석/진행 | 100,000 | National | Regularly | 114998337721 |
| We represent the needs and concerns of our target population in joint discussions with regulatory authorities and industry stakeholders across a range of networks. | 부인과
> 부인과: 기타 | 규제 파트너십
> 정책 입안자/규제 기관과의 회의 참석/진행 | 100,000 | National | Sometimes | 115028466428 |
| We submit statements to regulatory channels from a patient perspective. | 암
> 암: 대부분의 유형 | 규제 파트너십
> 정책 입안자/규제 기관과의 회의 참석/진행 | Do not know | National | Regularly | 115040330840 |
| Occasional position statements and opinions, often issued jointly with another organisation or under the auspices of an umbrella body. | 류마티스성
> 루푸스 | 규제 파트너십
> 다른 의료 지지자들과 함께 | 5,000 | National | Rarely | 115002845827 |
| Where there is a need to advocate or submit a formal statement, for example, we do so. | 일반 건강
> 성 건강: 기타 | 정책 및 법률에 영향 미치기
> 의료 정책 및 법률에 영향력 행사 | 10,000 | National | Rarely | 115000148067 |
| We provide formal submissions, and I have personally participated in consultation processes — for example, as part of the working group tasked with developing the pharmaceutical reimbursement system. | 뼈
> 골관절염 | 정책 및 법률에 영향 미치기
> 공청회 및 협의에 참여하기 | 10,000 | National | Regularly | 114998343058 |
| We submit consultation responses. | 뼈
> 골관절염 | 정책 및 법률에 영향 미치기
> 공청회 및 협의에 참여하기 | 10,000 | National | Regularly | 114998343058 |
| Engagement with the city and the wellbeing services county to extend free pharmaceutical treatment to type 2 diabetes medicines. | 내분비
> 당뇨병(1형 및 2형 모두) | 가격 책정 및 affordability 옹호
> 공정한 의약품 가격 책정 옹호 | 1,000 | Regional | Sometimes | 115006989892 |
| Medicine pricing, Kela [Kansaneläkelaitos – Social Insurance Institution of Finland] reimbursement procedures, pharmacy services, and out-of-pocket medicine costs. | 장애
> 장애: 대부분의 유형 | 가격 책정 및 affordability 옹호
> 공정한 의약품 가격 책정 옹호 | 1,000 | National | Regularly | 115007749998 |
| The price of obesity medicines. | 환자 권익 옹호
> 건강 활동가 | 가격 책정 및 affordability 옹호
> 공정한 의약품 가격 책정 옹호 | 1,000 | National | Sometimes | 115060416441 |
| For example, the Kela [Kansaneläkelaitos – Social Insurance Institution of Finland] medicine credit pilot [a Finnish policy experiment designed to help low-income patients afford high-cost prescription medicines when they face a large out-of-pocket payment all at once], which commenced on 27 October and will run for three years. | 스킨
> 건선 | 가격 책정 및 affordability 옹호
> 저소득층 및 취약계층의 비용 장벽 해소 | 10,000 | National | Regularly | 115000293575 |
| Medicine pricing, Kela [Kansaneläkelaitos – Social Insurance Institution of Finland] reimbursement procedures, pharmacy services, and out-of-pocket medicine costs. | 장애
> 장애: 대부분의 유형 | 가격 책정 및 affordability 옹호
> 저소득층 및 취약계층의 비용 장벽 해소 | 1,000 | National | Regularly | 115007749998 |
| Engagement with the city and the wellbeing services county to extend free pharmaceutical treatment to type 2 diabetes medicines. | 내분비
> 당뇨병(1형 및 2형 모두) | 가격 책정 및 affordability 옹호
> 제품의 급여 목록/국가 처방집 등재 옹호 | 1,000 | Regional | Sometimes | 115006989892 |
| Patient organisation submissions to promote medicine reimbursement and access. | 신경근
> 근이영양증 | 가격 책정 및 affordability 옹호
> 제품의 급여 목록/국가 처방집 등재 옹호 | 5,000 | National | Regularly | 115007479426 |
| Medicine pricing, Kela [Kansaneläkelaitos – Social Insurance Institution of Finland] reimbursement procedures, pharmacy services, and out-of-pocket medicine costs. | 장애
> 장애: 대부분의 유형 | 가격 책정 및 affordability 옹호
> 제품의 급여 목록/국가 처방집 등재 옹호 | 1,000 | National | Regularly | 115007749998 |
| For example, the Kela [Kansaneläkelaitos – Social Insurance Institution of Finland] medicine credit pilot [a Finnish policy experiment designed to help low-income patients afford high-cost prescription medicines when they face a large out-of-pocket payment all at once], which commenced on 27 October and will run for three years. | 스킨
> 건선 | 접근 경로 개선
> 의약품/의료서비스에 대한 공평한 접근 촉진 | 10,000 | National | Regularly | 115000293575 |
| Engagement with the city and the wellbeing services county to extend free pharmaceutical treatment to type 2 diabetes medicines. | 내분비
> 당뇨병(1형 및 2형 모두) | 접근 경로 개선
> 의약품/의료서비스에 대한 공평한 접근 촉진 | 1,000 | Regional | Sometimes | 115006989892 |
| Patient organisation submissions to promote medicine reimbursement and access. | 신경근
> 근이영양증 | 접근 경로 개선
> 의약품/의료서비스에 대한 공평한 접근 촉진 | 5,000 | National | Regularly | 115007479426 |
| We are a patient organisation representing individuals living with osteoporosis, and we advocate for the patient perspective in all our interactions with regulatory authorities. | 뼈
> 골다공증 | 근거 기반 환자 의견
> 환자 인사이트를 활용하여 의사 결정에 반영하세요 | 100,000 | National | Regularly | 114998337721 |
| We submit statements to regulatory channels from a patient perspective. | 암
> 암: 대부분의 유형 | 근거 기반 환자 의견
> 환자 인사이트를 활용하여 의사 결정에 반영하세요 | Do not know | National | Regularly | 115040330840 |
| ... We are represented on Fimea's [Lääkealan turvallisuus- ja kehittämiskeskus – Finnish Medicines Agency] patient advisory board. | 지정되지 않음
> 지정되지 않음 | 기관 거버넌스
> 정부 자문 기구 내 대표성 확보 | 10,000 | National | Sometimes | 114998339214 |
상호작용
활동 및 옹호
8 멘션
